Pharmacology of dimethyl sulfoxide in cardiac and CNS damage

Stanley W. Jacob, Jack C. de la Torre

Research output: Contribution to journalReview article

70 Scopus citations

Abstract

The pharmacological effects of dimethyl sulfoxide (DMSO) administration include some desirable properties that may be useful in the treatment of medical disorders resulting in tissue injury and compromised organ systems. These properties include the reported effects of DMSO on impaired blood flow, suppression of cytotoxicity from excess glutamate release that may result in lethal NMDA-AMPA activation, restriction of cytotoxic Na+ and Ca+ entry into damaged cells, blocking tissue factor (TF) from contributing to thrombosis, reduction of intracranial pressure, tissue edema, and inflammatory reactions, and inhibition of vascular smooth muscle cell migration and proliferation that can lead to atherosclerosis of the coronary, peripheral, and cerebral circulation. A review of the basic and clinical literature on the biological actions of DMSO in cardiac and central nervous system (CNS) damage or dysfunction indicates that this agent, alone or in combination with other synergistic molecules, has been reported to neutralize or attenuate pathological complications that harmed or can further harm these two organ systems. The effects of DMSO make it potentially useful in the treatment of medical disorders involving head and spinal cord injury, stroke, memory dysfunction, and ischemic heart disease.

Original languageEnglish (US)
Pages (from-to)225-235
Number of pages11
JournalPharmacological Reports
Volume61
Issue number2
DOIs
StatePublished - Jan 1 2009

Keywords

  • DMSO
  • Dimethyl sulfoxide
  • Heart disease
  • Spinal cord trauma
  • Stents
  • Stroke
  • Traumatic brain injury

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Pharmacology of dimethyl sulfoxide in cardiac and CNS damage'. Together they form a unique fingerprint.

  • Cite this